Sociedad Americana de Hirudoterapia

Achieving Textbook Outcomes in Bilateral DIEP Flap Breast Reconstruction: Does a Co-Surgeon Matter?

Research article published in Journal of reconstructive microsurgery (2025)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Observational studyEnsayos clínicosDeVito et al. · Journal of reconstructive microsurgery, 2025

Abstract

BACKGROUND: It is essential to examine predictors of ideal outcomes in surgery. "Textbook outcomes" are optimal surgical results based on multiple quality measures. It is important that patients have access to trusted centers that consistently produce high-quality surgical outcomes. METHODS: A retrospective review of all bilateral Deep Inferior Epigastric Perforator (DIEP) flap breast reconstructions at our institution from 2017 to 2022 was performed. Criteria for "textbook outcome" were operating room (OR) time within one standard deviation of institutional average or less, length of stay ≤ 4 days, no intraoperative complications, no operative complications, no readmission within 30 days, no infection requiring IV antibiotics, no systemic complications, and no mortality. Propensity score matching was used to control for common comorbidities, reconstruction timing, and oncologic factors. This resulted in 47 matched pairs of bilateral DIEP flap reconstructions for comparison between a single-surgeon cohort and a co-surgeon cohort. RESULTS: Textbook outcomes occurred at a significantly higher rate in the co-surgeon cohort compared with the single surgeon cohort (79% vs. 57%, p = 0.025). The average OR time was significantly shorter in the co-surgeon cohort compared with the single surgeon cohort (403 minutes vs. 572 minutes, p < 0.0001), and elevated OR time was the most common reason for not achieving a textbook outcome. There were no differences in the other criteria for a "textbook outcome." CONCLUSION: Textbook outcomes in bilateral DIEP flap breast reconstruction are achieved at significantly higher rates with a co-surgeon. This is primarily due to significantly shorter OR times. Further research into factors affecting textbook outcomes is needed.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal Article
Indexed MeSH termsRetrospective StudiesOperative TimeLength of StayTreatment OutcomeMammaplastyPropensity ScoreHumansMaleFemaleMiddle AgedOutcome Assessment, Health CareSurgeons

Resumen

It is essential to examine predictors of ideal outcomes in surgery. "Textbook outcomes" are optimal surgical results based on multiple quality measures.

Por qué esto importa para la hirudoterapia

Esta revisión retrospectiva utilizó emparejamiento por puntaje de propensión para comparar 47 pares de reconstrucciones mamarias con colgajo DIEP bilateral realizadas por un único cirujano frente a un equipo de dos cirujanos. Se hallaron tasas más altas de 'resultado acorde a los estándares' en la cohorte con dos cirujanos (79 % frente a 57 %; p=0,025), debido principalmente a un menor tiempo quirúrgico promedio en quirófano (403 frente a 572 minutos; p<0,0001), sin diferencias significativas en los demás criterios evaluados. El estudio aborda la configuración del equipo quirúrgico y la eficiencia operatoria en la reconstrucción mamaria autóloga. No menciona sanguijuelas, hirudoterapia, rescate del colgajo por congestión venosa ni el secretoma de la sanguijuela, por lo que no aporta evidencia directa sobre la hirudoterapia y no puede establecerse un vínculo defendible con la terapia con sanguijuelas a partir de este resumen.

Citación

Achieving Textbook Outcomes in Bilateral DIEP Flap Breast Reconstruction: Does a Co-Surgeon Matter?

DeVito et al. · Journal of reconstructive microsurgery, 2025

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.